FOR PHARMA & LIFE SCIENCES
TM
Fact Sheet
ANSWERS BASED ON COMPREHENSIVE, UP-TO-DATE INFORMATION
Pharmaceutical companies need current and comprehensive information on
drugs and drug adverse events. With over 8,500 biomedical journals and in-depth,
full-text indexing of drugs, diseases and medical devices, this is just what Embase
is able to offer.
FOR PHARMA & LIFE SCIENCES
Introduction
With over 29 million indexed records and more than 8,500
currently indexed peer-reviewed journals, Embase is a highly
versatile, multipurpose and up-to-date database covering the
most important international biomedical literature from 1947 to
the present day.
• Support decision making with up-to-date and high-quality
preclinical and clinical information and stay abreast of the
competition
Fact Sheet
• Comply with legislation and regulations for drug safety and
pharmacovigilance
• Track precise drug information, including adverse events,
comparisons and therapy as well as disease information
Key Elements
3 key elements make Embase
the most comprehensive and
authoritative online source of
drug-related information.
The most relevant results
The most relevant results – indexed in depth
using Elsevier’s unique life science thesaurus.
Emtree includes chemical names, trade names
and laboratory/ research codes mapped to
generic names for more than 31,000 drugs
and chemicals. It’s updated three times each
year, with backposting of older records in
Embase.com to bring them in line with the
current update.
Unique journal coverage
(titles NOT on MEDLINE)
Comprehensive content – over 29 million
records from more than 8,500 current peer
reviewed journals, including more than 2,800
titles not available on MEDLINE. For additional
currency, Embase.com includes Articles in Press
and “In Process” records (not yet fully indexed)
for the majority of articles.
Conference coverage
Over 5,500 conferences and more than 1.75
million conference abstracts published in
journals and journal supplements since 2009.
Embase is unique in its extensive coverage
of searchable conference abstracts.
2
FOR PHARMA & LIFE SCIENCES
Embase scope and content
Embase has a broad biomedical scope, with in-depth coverage of pharmacology,
pharmaceutical science and clinical research. Basic biomedical science, veterinary
science and extensive allied health topics are also included.
12%
28%
11%
10%
2%
2%
2%
2%
8%
3%
3%
7%
6%
6%
5% 4%
4%
4%
3%
3%
12%
Pharmacology & Toxicology
11%
General Clinical Medicine
10%
Genetics, Biochemistry & Molecular Biology
8%
Neurology & Behavioral Medicine
7%
Microbiology & Infectious Diseases
6%
Cardiology & Hematology
6%
Psychiatry & Mental Health
5%
Oncology
4%
Healthcare Policy & Management
4%
Allergy & Immunology
4%
Pediatrics
3%
Endocrinology & Metabolism
3%
Obstetrics & Gynecology
3%
Biomedical Engineering & Medical Devices
3%
Anesthesiology & Intensive Care
2%
Gastroenterology
2%
Respiratory Medicine
2%
Nephrology & Urology
2%
Dermatology
28%
Other
Summary Data
• 30 Core pharmacology and clinical topics* represent over 70%
of embase.com content (over 5,000 journal titles)
• With a total content exceeding 8,500 journal titles, embase.com
covers over 60 topic areas
• Over 30% of embase.com journal titles are unique**, including 30%
of titles covering core pharmacology and clinical topics
* The pie chart shows the core topics, grouped into 19 super categories.
** i.e. not covered by MEDLINE.
Drug Search on Embase.com
You can search for a drug by any name known to you, such as a generic name,
proprietary name, laboratory code, or chemical name: i.e: valium, loratadine or sch
29851. Synonyms are automatically mapped to Emtree preferred terms, as in Advanced
Search with Map to preferred term in Emtree selected: e.g. valium is mapped to the
preferred term ‘diazepam’.
Drug Subheadings
Drug Subheadings limit the records retrieved about the drug entered in the Drug name
text box to specific aspects, such as adverse drug reaction, drug therapy, drug toxicity,
etc. This increases precision when searching these topics. For example, Drug Therapy
will indicate all diseases treated with the indexed drug in the current study.
3
Learn More
To request information or a product demonstration,
please visit elsevier.com/embase or email us at
[email protected]
Visit www.elsevier.com/online-tools/corporate
or contact your nearest Elsevier office.
ASIA AND AUSTRALIA
EUROPE, MIDDLE EAST AND AFRICA
Tel: + 65 6349 0222
Tel: +31 20 485 3767
Email: [email protected]
Email: [email protected]
JAPAN
NORTH AMERICA, CENTRAL AMERICA AND CANADA
Tel: + 81 3 5561 5034
Tel: +1 888 615 4500
Email: [email protected]
Email: [email protected]
KOREA AND TAIWAN
SOUTH AMERICA
Tel: +82 2 6714 3000
Tel: +55 21 3970 9300
Email: [email protected]
Email: [email protected]
EMBASE, PHARMAPENDIUM and REAXYS are trademarks of Reed Elsevier Properties SA, used under license. Copyright© 2015 Elsevier B.V. All rights reserved.
April 2015